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Mice lacking NF-κB1 exhibit marked DNA damage
responses and more severe gastric pathology in
response to intraperitoneal tamoxifen administration
Michael D Burkitt1, Jonathan M Williams2, Tristan Townsend1, Rachael Hough1 and D Mark Pritchard*,1
Tamoxifen (TAM) has recently been shown to cause acute gastric atrophy and metaplasia in mice. We have previously
demonstrated that the outcome of Helicobacter felis infection, which induces similar gastric lesions in mice, is altered by deletion
of specific NF-κB subunits. Nfkb1−/− mice developed more severe gastric atrophy than wild-type (WT) mice 6 weeks after H. felis
infection. In contrast, Nfkb2−/−mice were protected from this pathology. We therefore hypothesized that gastric lesions induced by
TAM may be similarly regulated by signaling via NF-κB subunits. Groups of five female C57BL/6 (WT), Nfkb1−/−, Nfkb2−/− and
c-Rel−/− mice were administered 150 mg/kg TAM by IP injection. Seventy-two hours later, gastric corpus tissues were taken for
quantitative histological assessment. In addition, groups of six female WTand Nfkb1−/−mice were exposed to 12 Gy γ-irradiation.
Gastric epithelial apoptosis was quantified 6 and 48 h after irradiation. TAM induced gastric epithelial lesions in all strains of mice,
but this was more severe in Nfkb1−/− mice than in WT mice. Nfkb1−/− mice exhibited more severe parietal cell loss than WT mice,
had increased gastric epithelial expression of Ki67 and had an exaggerated gastric epithelial DNA damage response as quantified
by γH2AX. To investigate whether the difference in gastric epithelial DNA damage response of Nfkb1−/− mice was unique to
TAM-induced DNA damage or a generic consequence of DNA damage, we also assessed gastric epithelial apoptosis following
γ-irradiation. Six hours after γ-irradiation, gastric epithelial apoptosis was increased in the gastric corpus and antrum of Nfkb1−/−
mice. NF-κB1-mediated signaling regulates the development of gastric mucosal pathology following TAM administration. This is
associated with an exaggerated gastric epithelial DNA damage response. This aberrant response appears to reflect a more generic
sensitization of the gastric mucosa of Nfkb1−/− mice to DNA damage.
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Gastric cancer in humans is strongly associated with gastric
colonization with Helicobacter pylori.1 This leads, in a minority
of people, to a preneoplastic cascade of pathology that
develops over several decades. This cascade is typified by
gastric oxyntic gland atrophy, epithelial metaplasia, dysplasia
and cancer.2 These events can be modeled by infecting
C57BL/6 mice with the related bacterium Helicobacter felis. In
this model, advanced gastric preneoplasia develops over
12 months and, in some hands, malignancies have been
reported in animals aged 13–15 months.3,4
The development of gastric preneoplasia in response to
gastric Helicobacter infection occurs on the background of
chronic inflammation of the gastric mucosa. The signaling
pathways that regulate gastric epithelial remodeling in
response to chronic inflammation are complex and have not
been fully elucidated. However, there is a wealth of evidence
that signaling through NF-κB pathways is involved in the
development of inflammation-associated malignancies both in
the stomach and in other parts of the gastrointestinal tract.5
The NF-κB proteins are a group five of structurally related
transcription factors (RelA (p65), RelB, c-Rel, NF-κB1 (p50)
and NF-κB2 (p52)), which influence transcription through the
binding of homodimer or heterodimers of themselves to
chromatin. Activation of transcription through these proteins
is tightly regulated, both through a network of upstream
signaling kinases and by complex posttranscriptional mod-
ification of the NF-κB subunits. Two distinct NF-κB pathways
are conventionally described: the classical (canonical) path-
way is regulated by the activation of IKKβ, following stimuli
including TNF binding to its receptor, and activation of Toll-like
receptors. The principal NF-κB dimers activated by this
pathway are RelA/NF-κB1 dimers and RelA/c-Rel dimers. In
contrast, the alternative (non-canonical) NF-κB signaling
pathway is regulated by the kinase NIK and is characterized
by transcriptional regulation by dimers of RelB/NF-κB2
(see Merga et al.5 for a recent review of these pathways).
We have previously reported that H. felis-induced gastric
preneoplasia is differentially regulated by signaling involving
specific NF-κB subunits. Mice lacking the NF-κB1 subunit
developed more severe gastric atrophy after 6 weeks of
infection and more severe preneoplastic pathology when
infected for 12months. In contrast,Nfkb2−/−micewere entirely
protected from H. felis-induced pathology, despite heavy
colonization by these bacteria.6 This has also been demon-
strated in the context of acute inflammatory responses in the
intestinal tract where Nfkb2−/− mice exposed to low-dose
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lipopolysaccharide systemically were protected from patholo-
gical small intestinal villus tip epithelial cell shedding and
apoptosis, whereas Nfkb1−/−mice demonstrated more severe
lesions than wild-type (WT) mice.7
It has recently been reported that intraperitoneal adminis-
tration of tamoxifen to mice induces an acute gastric corpus
metaplasia, characterized by the loss of parietal cells,
metaplastic changes originating in the chief cells at the base
of the gastric glands and increased epithelial cell proliferation.8
These findings have been shown to be reproducible in other
laboratories,9 to be estrogen independent and reversible on
discontinuation of tamoxifen. Unlike H. felis-induced gastric
preneoplasia, this pathology occurs with relatively little
associated inflammation in the gastric mucosa;10 this model
therefore offers an opportunity to investigate gastric epithelial
remodeling in the absence of a chronic inflammatory stimulus.
We have utilized this model to characterize whether the
regulation of gastric preneoplasia by mice lacking specific
NF-κB subunits is a generic response to gastric epithelial
remodeling or specific to the events induced by H. felis
infection.
Results
Tamoxifen induced gastric corpus pathology is regulated
by Nfkb1. To characterize whether deletion of specific NF-κB
subunits altered the severity of pathology induced by
administration of tamoxifen, groups of at least five, 12-week
old, WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− female mice were
either treated with tamoxifen or vehicle and culled 72 h later.
Gastric pathology was scored using an established scoring
system.11 Vehicle-treated mice of all genotypes exhibited
minimal gastric lesions (Figures 1 and 2a). Following
administration of tamoxifen, morphological changes were
seen in the corpus mucosa of all groups of mice. Tamoxifen-
treated WT mice had mean pathology scores of 2.4 (±0.51
S.E.M.). Nfkb2−/− and c-Rel−/− mice exhibited similar lesion
scores, while Nfkb1−/− mice exhibited more severe gastric
lesions with a mean score of 4.8 (±0.74, Po0.01 by two-way
analysis of variance (ANOVA) and Dunnett’s post hoc test).
To quantify the degree of gastric atrophy induced by
tamoxifen, we assessed the number of H+/K+ATPase-
expressing cells. Among untreated mice, no significant
differences in the number or distribution of parietal cells were
identified between the mice of different genotypes. In all,
31.2% of cells in the gastric corpus of untreated WT mice
expressed H+/K+ ATPase (Figures 1 and 2b), and cells were
distributed between cell positions 2 and 36 of the gastric gland,
with peak prevalence at cell position 15 (Figure 2c).
Following administration of tamoxifen, the number of H+/
K+ATPase-expressing cells did not differ substantially in WT
mice, but a shift in parietal cell distribution up the gland was
noted (significantly higher numbers of parietal cells observed
between cell positions 18 and 36 in tamoxifen-treated mice,
Po0.05 by modified median testing, Figure 2c). In keeping
with the visual analog scoring of gastric lesions, similar
numbers and distributions of H+/K+ATPase-expressing cells
were identified in the corpus ofNfkb2−/− and c-Rel−/−mice that
had been exposed to tamoxifen (Figures 2b, e and f). In
contrast, Nfkb1−/− mice showed more marked changes in
parietal cell distribution than their WT counterparts, with a 2.4-
fold reduction in parietal cell number (Po0.001 by two-way
ANOVA and Dunnett’s post hoc analysis, Figure 2b), and a
marked reduction in parietal cell abundance between cell
Figure 1 Representative photomicrographs of gastric corpus of WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice treated with vehicle or 150 mg/kg tamoxifen. Sections stained
with hematoxylin and eosin or immunostained for the expression of H+/K+ATPase. Scale bars 100 μm
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positions 4 and 13 of gastric corpus glands (Po0.05 by
modified median testing, Figure 2d). To validate this observa-
tion and to determine whether the observed effects of
tamoxifen were likely due to an estrogen receptor-mediated
effect, we performed quantitative real-time PCR on gastric
mucosal samples from WTand Nfkb1−/− mice that had or had
not been treated with tamoxifen. These assays demonstrated
reduced transcription of ATP4A (encoding H+/K+ATPase) in
tamoxifen-treated WTand Nfkb1−/−mice but no differences in
the expression of estrogen receptor-regulated genes Erbb2 or
Wnt5A (Supplementary Figure 1).
Nfkb1-mediated signaling regulates tamoxifen-induced
cell proliferation. To determine whether NF-κB signaling
influenced gastric epithelial cell turnover following the
administration of tamoxifen, we quantified cells expressing
the S-phase marker Ki67 and those undergoing apoptosis by
the expression of cleaved caspase 3.
In untreated mice, genotype did not significantly influence
the number of cleaved caspase 3-positive cells, which
were relatively rare occurrences (1.4±0.68 S.E.M.
cells per high-power (×40 objective) field). However, there
was a trend toward more apoptosis in both Nfkb1−/− and
Nfkb2−/− mice. Administration of tamoxifen to WT mice
increased the number of cleaved caspase 3-positive cells
3.4-fold, but this did not reach statistical significance
(Figures 3a and b). In both Nfkb1−/− and Nfkb2−/− mice,
tamoxifen induced apoptosis in a larger number of apoptotic
cells than inWTmice (3.9- and 4.8-fold, Po0.05 and Po0.01,
respectively).
Figure 2 Tamoxifen-induced epithelial lesions in WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice. (a) Visual analog scoring of pathology identified in hematoxylin and eosin-
stained sections from mice treated with vehicle or 150 mg/kg tamoxifen. (b) Percentage of gastric corpus gland cells expressing H+/K+ATPase in mice treated with vehicle or
150 mg/kg tamoxifen. For panels (a and b), statistically significant differences tested by two-way ANOVA and Dunnett’s test. **Po0.01, ***Po0.001, ****Po0.0001. (c–f):
H+/K+ATPase-positive cells plotted by cell position in the gastric corpus hemiglands of WT (c), Nfkb1−/− (d), Nfkb2−/−(e) and c-Rel−/−(f). Solid line represents distribution of cells
in vehicle-treated mice, broken line tamoxifen-treated mice. Shaded area marks region of gland where distribution of H+/K+ATPase-positive cells differs significantly in tamoxifen-
treated versus vehicle-treated mice, Po0.05 by modified median test. N= 5 for all experimental groups
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In untreated WT mice, 18.1% (±0.7) of gastric corpus
epithelial cells were in S phase. They were distributed between
cell positions 5 and 32; peak proliferative indexwas observed at
cell positions 15 and 16. Proliferating cells were more abundant
in untreated Nfkb1−/− mice, compared with WT (26.6%±1.9,
Po0.05 by two-way ANOVA and Dunnett’s post hoc test); in
this genotype, peak proliferative index was observed at cell
position 14, and proliferating cells were observed between cell
positions 2 and 29. Other untreated transgenic mice exhibited
similar proliferation indices to WT mice.
Following tamoxifen treatment, the number of proliferating
cells observed in WT mice increased 1.8-fold (Po0.01,
Figures 3a, c and d). This increase was recapitulated in other
genotypes of mice (Figures 3a, c and e–g) but was more
pronounced in Nfkb1−/− mice than other groups, where a
2.4-fold increase in proliferating cells was observed
(Po0.0001 compared with tamoxifen-treated WT mice,
Figure 3c). In these animals, proliferating cells were observed
between cell positions 2 and 52, with peak proliferative index
at cell position 16.
Figure 3 Gastric corpus epithelial cell turnover following tamoxifen administration in WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice. (a) Representative photomicrographs of
gastric corpus of WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/−mice treated with 150 mg/kg tamoxifen. Sections immunostained for expression of cleaved caspase-3 or Ki67. Scale bars
100 μm. (b) Number of cleaved-caspase 3-positive cells identified per high-power field in mice treated with vehicle or 150 mg/kg tamoxifen. (c) Percentage of gastric corpus gland
cells expressing Ki67 in mice treated with vehicle or 150 mg/kg tamoxifen. For panels (b and c), statistically significant differences tested by two-way ANOVA and Dunnett’s test.
*Po0.05, **Po0.01, ****Po0.0001. (c–f) Ki67-positive cells plotted by cell position in the gastric corpus hemiglands of WT (d), Nfkb1−/− (e), Nfkb2−/−(f) and c-Rel−/−(g) mice.
Solid line represents distribution of cells in vehicle-treated mice, broken line tamoxifen-treated mice. Shaded area marks region of gland where distribution of Ki67-positive cells
differs significantly in tamoxifen-treated versus vehicle-treated mice, Po0.05 by modified median test. N= 5 for all experimental groups
Figure 4 Gastric corpus expression of γ-H2AX following tamoxifen administration in WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice. (a) Representative photomicrographs of
gastric corpus of WT, Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice treated with 150 mg/kg tamoxifen. Sections immunostained for expression of γ-H2AX. Scale bars 100 μm.
(b) Percentage of gastric corpus gland cells expressing γ-H2AX in mice treated with vehicle or 150 mg/kg tamoxifen. Statistically significant differences tested by two-way ANOVA
and Dunnett’s test. **Po0.01, ***Po0.001. (b–e) γ-H2AX-positive cells plotted by cell position in the gastric corpus hemiglands of WT (c), Nfkb1−/− (d), Nfkb2−/−(e) and
c-Rel−/−(f) mice. Solid line represents distribution of cells in vehicle-treated mice, broken line tamoxifen-treated mice. Shaded area marks region of gland where distribution of
γ-H2AX cells differs significantly in tamoxifen-treated versus vehicle-treated mice, Po0.05 by modified median test. N= 5 for all groups
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Nfkb1 regulates tamoxifen-induced DNA damage in the
gastric epithelium. To investigate the mechanism under-
lying differences in sensitivity to tamoxifen-induced gastric
pathology, we assessed whether there were any aberrant
DNA damage responses. Although tamoxifen is best char-
acterized as an anti-estrogen receptor drug, it is also a
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genotoxic agent. DNA damage induced by tamoxifen is
associated with the formation of tamoxifen/DNA adducts and
with the induction of oxidative stress by tamoxifen
metabolites.12 This mechanism has been hypothesized to
be of clinical relevance in patients treated with tamoxifen, who
have an increased risk of some malignancies, including
endometrial cancer.13 We hypothesized therefore that this
effect may influence the degree of gastric pathology induced
by tamoxifen.
To quantify this, we immunostained tissue sections using a
phospho-specific antibody targeting γ-H2AX, which reflects a
DNA damage response in the cell. In untreated gastric corpus
mucosa, γ-H2AX was identified in 2.8% of WTepithelial cells.
All untreated transgenic groups had similar percentages of
γ-H2AX-labeled cells to WT mice (Figures 4a–f). There was a
small increase in abundance of γ-H2AX following tamoxifen
treatment of WT mice (4.6%), but this did not reach statistical
significance. A similar trend toward increased abundance of
γ-H2AX was observed in Nfkb2−/− and c-Rel−/− mice admin-
istered tamoxifen. In contrast, the percentage of γ-H2AX-
labeled cells increased 4.0-fold in Nfkb1−/−mice administered
tamoxifen (Po0.001, Figure 4b). Excess γ-H2AX expression
occurred over a wide gland area in this strain (between cell
positions 5 and 32 of the gastric corpus gland, Figure 4d). In
tamoxifen-treated Nfkb1−/− mice, γ-H2AX expression was
observed between cell positions 2 and 39, with peak γ-H2AX
expression observed at cell position 20 (Figure 4d).
Previous studies have suggested that the administration of
tamoxifen specifically induced gastric parietal cell death. To
characterizewhich cell types experienced DNA damage in our
studies, we performed co-immunofluorescence studies with
immunostaining for both H+/K+ATPase and γ-H2AX. These
assays demonstrated that, while some γ-H2AX-positive cells
were parietal cells, other γ-H2AX-positive cells did not express
H+/K+ATPase (Supplementary Figure 2). Because of the
differences in proliferation indices observed in Nfkb1−/− mice
following TAM administration, we also wanted to determine
whether DNA damage, identified by γ-H2AX immunostaining,
colocalized predominantly with proliferating cells. To do this,
we performed γ-H2AX/Ki67 co-immunostaining. This assay
demonstrated that, although a proportion of γ-H2AX stained
cells were in S phase following tamoxifen administration, the
others did not appear to be proliferating (Supplementary
Figure 3).
Nfkb1−/− mice also have aberrant responses to
γ-irradiation induced DNA damage. We next wanted to
characterize whether the differences identified in γ-H2AX
expression in Nfkb1−/− mice were due specifically to altered
responses to the genotoxic stress induced by tamoxifen or
represented a more generic aberrant response to DNA
damage. To address this, we quantified gastric epithelial cell
turnover in both the gastric corpus and antrum at baseline
and 6 and 48 h following 12 Gy γ-irradiation by cell positional
scoring of morphologically apoptotic and mitotic cells. This
dose and time points of γ-irradiation have previously been
demonstrated to be optimal for the assessment of DNA
damage-induced apoptosis in the stomach, and morphologi-
cal assessment of H+E-stained sections correlates well with
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Figure 5 Impact of NF-κB subunit deletion on gastric gland length (a and b), number of gastric epithelial cells undergoing mitosis (c and d) and location of mitoses within the
gastric gland (e and f) of untreated mice. Panels (a, c and e) represent events in the gastric antral mucosa; panels (b, d and f) show data from the gastric corpus. Statistically
significant differences tested by one-way ANOVA and Dunnett’s test (a–d), **Po0.01, ***Po0.001 ****Po0.0001. (e and f) Solid line represents distribution of mitotic cells in
WT mice, dashed line Nfkb1−/−, dotted line Nfkb2−/−, dot and dash line c-Rel−/−mice. Shaded area marks region of gland where distribution of mitotic cells differs significantly in
WT versus Nfkb1−/− mice, Po0.05 by modified median test. N= 6 for all experimental groups
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other markers of apoptosis, including cleaved-caspase 3
immunostaining and TUNEL staining.14
In untreated age matched, young adult WT mice, gastric
antral glandswere 19.1 (±1.9) cells in length on average, while
corpus glands were a mean 31.1 (±1.7) cells long. Deletion of
NF-κB subunits did not significantly alter the length of gastric
corpus glands, while in the antrum, gastric gland hyperplasia
to a mean gland length of 24.2 cells (±2.6, Po0.01) was
observed in Nfkb1−/−mice and to 25.1 cells (±1.6, Po0.01) in
Nfkb2−/− mice (Figures 5a and b).
An average of 0.66% (±0.24) of antral gland cells were
mitotic in untreated WT mice, and these were distributed
between cell positions 3 and 15 with peak mitotic index at cell
position 7. In Nfkb1−/− mice, the number of mitotic cells
observed was higher (1.6 ±0.73%, Po0.05, Figure 5c), and
the distribution of mitoses occurred over a wider area (cell
positions 4–25), with the position of peak mitotic index shifted
up the gland to cell position 14. Statistically significant
increases in mitotic indices were observed at cell positions
11–22 in Nfkb1−/− compared with WT mice (Po0.05,
Figure 5e). No statistically significant differences in the
number or distribution of mitotic cells were identified in the
gastric mucosae of mice lacking NF-κB2 or c-Rel.
In gastric corpus mucosa, 0.25% (±0.10) of cells were
mitotic in WT mice (Figure 5d). These events were distributed
between cell positions 10 and 31, with peak mitotic index at
cell position 14 (Figures 5d and f). In Nfkb1−/− mice, 1.1%
(±0.29, Po0.0001) of gastric corpus cells were mitotic and
mitotic cells were distributed between cell positions 11 and 32,
with peak mitotic index at cell position 19. Increased gastric
corpus mitotic index (Po0.05) was observed in Nfkb1−/−mice
compared with WT mice between cell positions 16 and 25
(Figures 5d and f).
In untreated WT mice, 0.17% (±0.25) of cells in the gastric
antrum were identified as morphologically apoptotic; these
events were distributed in low numbers from cell position 4
to 12. Neither the number nor the distribution of apoptotic cells
was significantly different in the antrum of untreated Nfkb1−/−
mice (Figures 6a, c and e). In the corpus of untreatedWTmice,
0.04% (±0.04) of cells were morphologically apoptotic and
were distributed between cell positions 8 and 26. By this
measure, the number of apoptotic cells in the gastric corpus
was increased 4.8-fold in untreated Nfkb1−/− mice
(0.19%± 0.15, Po0.05), and the apoptotic cells were
distributed over a marginally wider region of the corpus gland
than in WT mice (cell positions 5–32) (Figures 6b, d and f).
γ-Irradiation entirely suppressed mitosis in the gastric
tissues of both WT and Nfkb1−/− mice at both 6- and 48-h
after irradiation. However, 6 h after γ-irradiation, the numbers
of apoptotic cells identified in both the corpus and antrum of
Nfkb1−/− mice were higher than in similar tissues from WT
mice (Figures 6c and d). In the antrum, 2.8% (±1.1) of gastric
antral cells were apoptotic in WT mice, with apoptotic cells
distributed between cell positions 2 and 17 and peak apoptotic
index at cell position 6. Six hours after γ-irradiation, 4.4%
(±1.5, Po0.05) of antral cells were apoptotic inNfkb1−/−mice,
with apoptotic cells observed between cell positions 2 and 24
and peak apoptotic index at cell position 7. Significantly
increased apoptosis was observed in Nfkb1−/− mice between
cell positions 10 and 17 (Po0.05, Figure 6g).
Six hours after γ-irradiation, 0.34% (±0.04) cells were
apoptotic in the gastric corpus of WT mice, compared with
1.8% (±0.07) cells in Nfkb1−/− mice (Po0.0001). Apoptotic
cells were distributed between cell positions 9 and 28 in WT
mice, with peak apoptotic indices observed at cell positions 13
and 19. In Nfkb1−/− mice, apoptosis was observed between
cell positions 6 and 33, with peak apoptosis at cell position 18.
Increased apoptosis was observed in the gastric corpus of
Nfkb1−/− mice between cell positions 9 and 25 (Po0.05,
Figure 6h).
Figure 6 Impact of NF-κB1 deletion on gastric epithelial apoptosis in untreated and 12 Gy γ-irradiated mice 6 and 48 h after irradiation. (a and b) Representative images of
gastric corpus and antrum respectively stained with hematoxylin and eosin, arrows highlight apoptotic epithelial cells. Scale bars 100 μm. (c and d) Percentage of gastric
epithelial cells undergoing apoptosis in gastric antrum and corpus, respectively. Statistically significant differences tested by two-way ANOVA and Dunnett’s test. *Po0.05,
***Po0.001. (e–j) Apoptotic cells plotted by cell position in the gastric antrum (e, g and i) and corpus (f, h and j) of untreated and irradiated WTand Nfkb1−/− mice. Solid lines
represent distribution of cells in WT mice, broken lines Nfkb1−/− mice. Shaded areas mark regions of glands where distribution of apoptotic cells differs significantly in WT versus
Nfkb1−/− mice, Po0.05 by modified median test. N= 6 for all experimental groups
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Forty-eight hours after γ-irradiation, the differences in
apoptotic cell number between WT and Nfkb1−/− mice were
less marked, particularly in the gastric antrum. At this time
point, 5.2% (±2.0) of antral epithelial cells were apoptotic in
WT mice, compared with 3.6% of cells in Nfkb1−/− mice
(P=0.10, Figure 6c). Apoptosis was observed in WT mice
between cell positions 2 and 20, with peak apoptosis at cell
position 5. The distribution of apoptosis in Nfkb1−/− mice was
shifted slightly up the antral gland compared with WT mice,
with apoptotic cells being observed between cell positions 2
and 23 and peak apoptosis at cell position 8. Increased
apoptosis was observed in Nfkb1−/− mice between cell
positions 10 and 18 (Po0.05, Figure 6i).
In the gastric corpus, 1.2% (±0.09) of cells were apoptotic in
WT mice 48 h after γ-irradiation, compared with 2.3% (±0.60)
in Nfkb1−/− mice (Po0.05 Figure 6d). At this time point,
apoptotic cells were observed between cell positions 4 and 30,
with peak apoptosis at cell positions 17 and 18 in WT mice. In
Nfkb1−/− mice, apoptotic cells were observed between cell
positions 9 and 35, with peak apoptosis at cell position 14.
Increased apoptosis was observed between cell positions 9
and 21 (Po0.05, Figure 6j).
Nfkb1−/− animals have primed extrinsic pathway apopto-
sis mechanisms in the gastric epithelium. To investigate
the mechanism underlying the increased gastric epithelial
apoptosis in mice lacking Nfkb1, we extracted mRNA from
mucosal samples of mice either without treatment or 6 h
following γ-irradiation. We performed real-time PCR assays to
quantify the expression of eight regulators of apoptosis that
have previously been shown to be under the transcriptional
regulation of NF-κB signaling.15–21 No statistically significant
differences in the expression of the inhibitors of apoptosis
c-IAP1, c-IAP2 or xIAP were identified (Figures 7a–c) nor
were changes in the expression of p53, BCl-2 or BCLXL
observed (Figures 7d–f). In contrast, Fas and FasL expres-
sion levels were both upregulated (1.8- and 4.8-fold, Po0.01
and Po0.0001 respectively, Figures 7g and h) in the gastric
mucosa of untreated Nfkb1−/− mice compared with WT mice.
Six hours after γ-irradiation, Fas and FasL transcript
abundance increased in WT mice to levels similar to those
identified in Nfkb1−/− mice at baseline, suggesting that this
pathway is activated in response to γ-irradiation.
Discussion
These data demonstrate that NF-κB signaling is involved in
regulating the development of gastric epithelial metaplasia and
atrophy following tamoxifen administration. In this model, the
most significant NF-κB subunit appears to be NF-κB1, as mice
lacking NF-κB2 and c-Rel demonstrated few differences in
response compared withWTmice. This contrastswith previous
observations from our own laboratory that have demonstrated
differential regulation of H. felis-induced gastric preneoplastic
pathology in mice lacking NF-κB2 as well as NF-κB1.
The differences in gastric epithelial pathology observed in
Nfkb1−/− mice following tamoxifen administration were asso-
ciated with a more pronounced proliferative response and
increased epithelial cell apoptosis. This increase in prolifera-
tion was observed throughout the gland. This is consistent
with recent reports by Burclaff et al.22 that describe the
development of a metaplastic progenitor source following
tamoxifen-induced dedifferentiation of chief cells.
Further investigation of the DNA damage responses of
Nfkb1−/− mice demonstrated an increased sensitivity to
γ-irradiation-induced epithelial cell apoptosis than WT mice.
This suggests that the difference in response to tamoxifenmay
reflect a more generalized difference in DNA damage
responses in these mice, rather than a specific tamoxifen-
related event. This is supported by earlier studies which have
shown that, following γ-irradiation, Nfkb1−/− mice exhibited
more small intestinal apoptosis than WT mice.23
The dynamics of NF-κB- and p53-mediated signaling in
response to DNA damage have been subject to systematic
modeling in recent years.24 This work has demonstrated that
these mechanisms are closely linked and form a complex
regulatory network for DNA damage responses. It is therefore
unsurprising that abrogation of NF-κB signaling pathways
leads to altered DNA damage responses. Nonetheless, it is
striking that following tamoxifen administration this effect was
almost exclusively associated with NF-κB1 deletion.
We adopted a candidate gene approach to try to identify
specific targets of NF-κB signaling that could explain the
observed differences in apoptosis. Although there are
compromises associated with this approach, we identified
potential priming of the CD95/FasL pathway in untreated mice
lacking NF-κB1. Although this pathway is not the most
frequently studied in DNA damage-induced apoptosis, there
are both in vitro25 and in vivo26 studies that demonstrate its
role in modulating radiation-induced apoptosis. Further
studies that address the functional effect of components of
this pathway on tamoxifen-induced gastric lesions may
provide further insight into this mechanism.
Previous data have demonstrated that gastric epithelial
cells express the estrogen receptor, and hence a direct
abrogation of signaling through this receptor is a biologically
plausible mechanism for inducing gastric atrophy; however,
the similarity of lesions induced in the stomach following
tamoxifen with that induced by known protonophores including
DMP-777 has also promoted the concept of tamoxifen acting
as a direct epithelial cell toxin.10 Our DNA damage assays
suggest that genotoxic stress may contribute to the gastric
lesions induced by tamoxifen. However, further studies
investigating the underlying mechanism of tamoxifen-
induced gastric murine pathology are required.
We conclude that signaling involving NF-κB1 regulates
gastric epithelial pathology in response to a second model of
gastric atrophy and metaplasia. As in H. felis infection,
following tamoxifen administration, signaling mediated by
NF-κB1 appears to suppress gastric epithelial cell turnover
and DNA damage responses. This is coupled with altered
baseline expression of Fas and FasL in mice lacking NF-κB1,
which may contribute to excess apoptosis following genotoxic
stress. Given that these animals demonstrate differences in
susceptibility to both genotoxic stress and susceptibility to
gastric preneoplasia, further studies investigating how abro-
gation of NF-κB signaling pathways influences chemical
carcinogen-induced gastric carcinogenesis would provide
interesting insight into the importance of these pathways
during gastric carcinogenesis.
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Figure 7 Relative gene expression of specified regulators of apoptosis under transcriptional regulation of NF-κB signaling. Filled bars represent untreated mice, open
bars animals culled 6 h after 12 Gy γ-irradiation. Mean and S.D of Log2-transformed relative abundance for each transcript are plotted. Statistically significant differences tested
by two-way ANOVA and Dunnett’s test, *Po0.05, **Po0.01, ***Po0.001. N= 3 for all experimental groups. Panels show expression of the following transcripts: (a) c-IAP!,
(b) c-IAP2, (c) x-IAP, (d) p53, (e) BCL-2, (f) BCL-xL, (g) Fas, (h) FasL
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In the current study, we observed no differences between
WTand Nfkb2−/− mice. This is in contrast to H. felis infection,
following which Nfkb2−/− mice were almost entirely protected
from gastric epithelial pathology. This contrast suggests that
the effects of Nfkb1 and Nfkb2 deletion on gastric epithelial
pathology are mediated through different mechanisms.
Materials and Methods
Mice. All murine procedures were performed at the University of Liverpool
Biomedical Services Unit in a specific pathogen-free research facility under
appropriate UK Home Office licensing and following University of Liverpool
Research Ethics Committee approval.
Animals were maintained with a standard 12-h light/dark cycle and received
standard rodent chow and water ad libitum throughout the experimental procedures.
Female C57BL/6 WT (WT) mice were purchased from Charles River (Margate, UK)
and maintained for a minimum 7-day acclimatization prior to use in experiments.
Nfkb1−/−, Nfkb2−/− and c-Rel−/− mice (as previously described27) were bred and
maintained on a C57BL/6 genetic background at the University of Liverpool.
Animal procedures. Tamoxifen (Cayman Chemicals, Cambridge Biosciences,
Cambridge, UK) was prepared as previously described in ethanol and corn oil.8
Groups of at least 5 female mice aged 10–12 weeks were administered either
150 mg/kg tamoxifen or vehicle via a single intraperitoneal injection. Seventy-two
hours later, animals were killed by cervical dislocation, and gastric tissues were
harvested for histology.
Whole-body γ-irradiation was performed by exposure to a Caesium-137 source in
a GammaCell closed source irradiator. Groups of at least 6 female mice aged
10–12 weeks were exposed to a single 12 Gy fraction of γ-irradiation. Animals were
returned to standard housing conditions prior to being killed at 6 or 48 h after
procedure by cervical dislocation. Gastric tissues were harvested for histology. In a
separate experiment, similar groups of three mice were treated identically prior to
cervical dislocation at 6 h. From these animals, the luminal surface of the stomach
was scraped to generate gastric mucosa-enriched samples and flash-frozen in liquid
nitrogen prior to nucleic acid extraction.
Immunohistochemistry. Standard immunohistochemical techniques were
adopted throughout. Heat-induced epitope retrieval was performed for all antigens in
sodium citrate buffer, pH 6.0. Primary antibodies used were rabbit anti-H+/K+ATPase
(Santa Cruz Biotechnology, Heidelberg, Germany, SC-84304), rabbit anti-Ki67
(AB16667, AbCam, Cambridge, UK) and rabbit anti-γH2AX (#9718, Cell Signalling,
New England Biolabs, Hertfordshire, UK). Secondary detection of all antibodies was
performed using IMMpress anti-Rabbit polymer (Vector Laboratories, Peterborough,
UK) and SigmaFast 3,3'-diaminobenzidine (Sigma-Aldrich, Dorset, UK).
Quantitative histology. Quantitative histology was performed using pre-
viously validated cell positional scoring systems for H+E-stained and immunohis-
tochemically stained tissues. Briefly, well-oriented gastric glands were identified and
individual cells were scored morphologically, or based on positive immunostaining,
starting with cell position 1 at the base of the gland and extending up the gland to
the luminal surface. Each gland unit scored from base to apex of the gland is
described as a hemigland; for each gastric corpus section, a total of 30 hemiglands
were scored.28 Visual analog scoring of gastric preneoplastic lesions was performed
as previously described by Rogers et al.11 Cleaved-caspase-3 immunostaining was
quantified based on the number of positively stained cells per high-powered field.
For this score, 10 non-overlapping fields of gastric mucosa were visualized using a
× 40 objective per tissue section. The number of positively stained cells per
high-power field was counted, and mean score per section was calculated.
Quantitative real-time PCR. Total RNA was extracted and reverse
transcribed using the Roche Highpure RNA Tissue Kit and Transcriptor Reverse
Transcription Kits, respectively. Real-Time PCR was performed on a Roche
LightCycler 488 instrument, and assays were designed using the Roche Universal
Probe Library. Details of primers, probes and amplicons are included in Table 1. All
real-time PCR reagents were sourced from Roche UK, Burgess Hill, UK.
Statistics. Statistical analyses were performed using GraphPad Prism 7
(Graphpad Software, La Jolla, CA, USA). Data were analyzed with two-tailed,
two-way Student’s t-test or two-way ANOVA and Dunnett’s post hoc analyses as
appropriate. Differences in cell positional distributions were assessed using a
modified median test as previously described.29
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